Conditions & diseases

systemic sclerosis

Observed in 418 articles across 8 journals.

Falling

Latest share0.22%

Change vs baseline-2.91 pp

Months observed11

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Journal of Scleroderma and Related Disorders391
RMD Open12
BMJ Open5
BMJ Case Reports4
JME Practical Bioethics2
Lupus Science & Medicine2
Occupational and Environmental Medicine1
Regional Anesthesia & Pain Medicine1

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

RMD Open · 2026-07-15

Expert viewpoint on endpoints in systemic sclerosis: current and future outlook

Phrase rank #1 · DOI 10.1136/rmdopen-2026-006784

RMD Open · 2026-06-09

Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study

Phrase rank #1 · DOI 10.1136/rmdopen-2025-006688

Journal of Scleroderma and Related Disorders · 2026-06-05

P.272 Efgartigimod PH20 subcutaneous in adults with systemic sclerosis: a phase 2, randomized, double-blinded, placebo-controlled, parallel-group study (eSScape

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.315

Journal of Scleroderma and Related Disorders · 2026-06-05

P.305 Do patients reported outcomes overlap with disease activity indices and severity scores in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.347

Journal of Scleroderma and Related Disorders · 2026-06-05

P.391 Exploring the link: systemic sclerosis and peripheral arterial disease – data from a tertiary centersystemic sclerosis (SSc) is a connective tissue disease characterized by fibrosis and vasculopathy

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.432

Journal of Scleroderma and Related Disorders · 2026-06-05

P.167 Breaking the barrier: intestinal permeability, malnutrition, and serological profiles in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.212

Journal of Scleroderma and Related Disorders · 2026-06-05

P.395 Hospital-based first diagnoses of systemic sclerosis: defining initial clinical presentations and diagnostic pathways

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.436

Journal of Scleroderma and Related Disorders · 2026-06-05

P.157 Left atrial strain reveals early myocardial involvement in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.202

Journal of Scleroderma and Related Disorders · 2026-06-05

P.237 Nailfold videocapillaroscopy in patients with suspected systemic sclerosis: a comparison of one-finger method versus eight-finger method

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.281

Journal of Scleroderma and Related Disorders · 2026-06-05

P.147 Prevalence and associated factors of resting electrocardiogram abnormalities in systemic sclerosis: a single-centre study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.192

Journal of Scleroderma and Related Disorders · 2026-06-05

P.007 Impact of occupational pollutant exposure on clinical and serological phenotypes in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.63

Journal of Scleroderma and Related Disorders · 2026-06-05

OC.35 Platelets’ metabolism and functions in very early diagnosis of systemic sclerosis and in established disease

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.35

Journal of Scleroderma and Related Disorders · 2026-06-05

P.091 Circulating levels of TL1A and DCR3 molecules and systemic sclerosis progression

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.142

Journal of Scleroderma and Related Disorders · 2026-06-05

P.257 Reset-SSc: clinical trial evaluating rese-cel (resecabtagene autoleucel), a fully human, autologous 4-1BB CD19-CAR T cell therapy in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.300

Journal of Scleroderma and Related Disorders · 2026-06-05

P.280 Evaluation of skin involvement and disease activity in Greek patients with systemic sclerosis treated with bosentan during a 18-month follow-up period: results from the cure clinical study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.323

Journal of Scleroderma and Related Disorders · 2026-06-05

P.205 Spatial insights into melanocyte niches in salt-and-pepper dyspigmentation of systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.249

Journal of Scleroderma and Related Disorders · 2026-06-05

P.158 Heart involvement in systemic sclerosis and prescleroderma mesasured by electrocardiogram, pro-BNP, and troponin T

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.203

Journal of Scleroderma and Related Disorders · 2026-06-05

P.139 Myocarditis in systemic sclerosis patients with positive anti-PM/Scl-100 antibodies: two cases treated with combination therapy of mycophenolate mofetil and rituximab

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.186

Journal of Scleroderma and Related Disorders · 2026-06-05

P.355 Pulmonary function decline in very early diagnosis of systemic sclerosis (VEDOSS): a retrospective longitudinal single-center study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.396

Journal of Scleroderma and Related Disorders · 2026-06-05

P.244 Validation of strong candidate RNA biomarkers for systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.288

Journal of Scleroderma and Related Disorders · 2026-06-05

P.054 Anti-NOR-90 autoantibodies and clinical associations in systemic sclerosis: an international retrospective cohort study

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.106

Journal of Scleroderma and Related Disorders · 2026-06-05

P.072 Acute kidney injury and its implication on kidney function in patients with systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.124

Journal of Scleroderma and Related Disorders · 2026-06-05

P.339 Upadacitinib in a rare systemic sclerosis–ankylosing spondylitis overlap

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.380

Journal of Scleroderma and Related Disorders · 2026-06-05

P.267 Tibusure: a phase 2, global, randomized, double-blind, placebo-controlled study with open-label extension to evaluate the efficacy, safety, and tolerability of tibulizumab in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.310

Journal of Scleroderma and Related Disorders · 2026-06-05

P.227 Identification of lipidomic biomarkers associated with disease progression in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.271

Journal of Scleroderma and Related Disorders · 2026-06-05

P.162 Assessment of the effectiveness of intravenous immunoglobulin therapy in gastrointestinal manifestations of systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.207

Journal of Scleroderma and Related Disorders · 2026-06-05

P.052 The role of TLR7 and TLR9 in the pathogenesis of systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.104

Journal of Scleroderma and Related Disorders · 2026-06-05

P.168 Prevalence and risk factors for oesophageal strictures in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.213

Journal of Scleroderma and Related Disorders · 2026-06-05

P.122 Correlation between IL-6 polymorphisms and the presence and severity of ILD in patients with systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.172

Journal of Scleroderma and Related Disorders · 2026-06-05

P.058 Dual role of extracellular vesicle size and concentration as inverse correlates in autoantibody profiling and organ involvement prediction in systemic sclerosis

Phrase rank #1 · DOI 10.1136/JSRD-2026-SSWC.110